Puma Biotechnology, Inc. vs Urovant Sciences
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Puma Biotechnology, Inc. and Urovant Sciences are worth about the same: $508 M and $512 M (market caps of Oct 19, 2026 for Puma Biotechnology, Inc. and Jan 1, 2021 for Urovant Sciences). Urovant Sciences's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Puma Biotechnology, Inc. PBYI · #12,484 in the world | Urovant Sciences UROV |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $508 M | $512 M* |
| Revenue | $228 M | — |
| Net income | $31 M | — |
| Valuation | ||
| P/E ratio | 21.3× | — |
| Price to sales | 2.2× | — |
| Price to book | 3.9× | — |
| Free cash flow yield | 8.2% | — |
| Profitability | ||
| Gross margin | 74.5% | — |
| Operating margin | 16.3% | — |
| Net margin | 13.6% | — |
| Return on equity | 28.0% | — |
| Return on invested capital | 30.3% | — |
| Growth | ||
| Revenue growth | -0.9% | — |
| Revenue growth, 3 years a year | 0.1% | — |
| Earnings per share growth | -1.6% | — |
| Financial strength | ||
| Debt to equity | 0.2× | — |
| Net debt to EBITDA | -0.1× | — |
| Cash | ||
| Free cash flow margin | 18.3% | — |
| Strength scores | ||
| Piotroski F-score | 7 of 9 | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2021 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Puma Biotechnology, Inc. or Urovant Sciences?
Puma Biotechnology, Inc. and Urovant Sciences are worth about the same: $508 M and $512 M (market caps of Oct 19, 2026 for Puma Biotechnology, Inc. and Jan 1, 2021 for Urovant Sciences). Urovant Sciences's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.
More about Puma Biotechnology, Inc.
More about Urovant Sciences
Sources#
Every figure on this page comes from these, with the date shown next to it.